share_log

Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Guy Wendy

Processa Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities

Processa Pharmaceuticals | 4：持股變動聲明
美股sec公告 ·  04/13 04:53
牛牛AI助理已提取核心訊息
On January 1, 2024, Wendy Guy, the Chief Administrative Officer of Processa Pharmaceuticals, Inc. (PCSA), completed a transaction involving the company's common stock. Guy executed a sale of 368 shares at a price of $2.79 per share, resulting in a total market value of $1,026.72. Following this transaction, Guy's direct holdings in Processa Pharmaceuticals decreased to 11,433 shares. Additionally, Guy holds an indirect interest in 8,335 shares through CorLyst, LLC. The transaction reflects a completed action as per the latest filing.
On January 1, 2024, Wendy Guy, the Chief Administrative Officer of Processa Pharmaceuticals, Inc. (PCSA), completed a transaction involving the company's common stock. Guy executed a sale of 368 shares at a price of $2.79 per share, resulting in a total market value of $1,026.72. Following this transaction, Guy's direct holdings in Processa Pharmaceuticals decreased to 11,433 shares. Additionally, Guy holds an indirect interest in 8,335 shares through CorLyst, LLC. The transaction reflects a completed action as per the latest filing.
2024年1月1日，Processa Pharmicals, Inc.（PCSA）的首席行政官溫迪·蓋伊完成了一項涉及該公司普通股的交易。蓋伊以每股2.79美元的價格出售了368股股票，總市值爲1,026.72美元。在這筆交易之後，蓋伊在Processa Pharmicals的直接持股量減少至11,433股。此外，蓋伊通過CorlyST, LLC間接持有8,335股股票的權益。根據最新申報文件，該交易反映了已完成的行動。
2024年1月1日，Processa Pharmicals, Inc.（PCSA）的首席行政官溫迪·蓋伊完成了一項涉及該公司普通股的交易。蓋伊以每股2.79美元的價格出售了368股股票，總市值爲1,026.72美元。在這筆交易之後，蓋伊在Processa Pharmicals的直接持股量減少至11,433股。此外，蓋伊通過CorlyST, LLC間接持有8,335股股票的權益。根據最新申報文件，該交易反映了已完成的行動。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。